NexPhase Capital Invests in Magic Science Corporation

NexPhase Capital Partners With Calcium

November 9, 2021

Marketing & Advertising

NexPhase Capital has made a financial investment in Calcium, a mid-sized healthcare marketing agency, to support the agency's strategic growth while keeping the existing management team in place. The partnership provides Calcium with financial backing to strengthen and expand its strategic, creative, and digital capabilities to better serve life-science clients.

PureTech Scientific (Iron Path Capital) Acquires Glycolic Acid Business from The Chemours Company for $137 Million

June 1, 2023

Manufacturing

PureTech Scientific, a company founded and backed by Iron Path Capital, agreed to acquire The Chemours Company's Glycolic Acid business for $137 million in cash. The transaction (a carve-out/divestiture) closed in August 2023 and creates a standalone platform focused on high‑purity alpha hydroxy acids for life sciences, specialty chemicals and personal care end markets.

Lake Street Capital Partners Recapitalizes Concrete Science Holdings; Concrete Science Acquires MD Concrete

August 28, 2024

Construction

Lake Street Capital Partners completed a majority recapitalization and partnership with Concrete Science Holdings, a Minneapolis-based concrete installation and coatings services platform. Concurrently, Concrete Science completed an add-on acquisition of MD Concrete to expand its geographic reach and service capabilities.

NexPhase Capital Invests in Aztec Software

April 26, 2022

Education

NexPhase Capital has made an investment in Aztec Software, an educational software company serving adult learners and workforce training markets. The capital will support Aztec's growth, expansion into adjacent markets and channels, and execution of its acquisition pipeline; NexPhase partners will join the company's board while Jonathan Blitt remains CEO. Terms were not disclosed.

Genesis Systems Acquires Molecule Inc.

May 1, 2023

Environmental Services

Genesis Systems LLC (Tampa, Florida) has acquired Molecule Inc., an emerging materials-sciences innovator, to expand its intellectual property and product portfolio for renewable water supply and utility-scale water-from-air technologies. The deal is intended to consolidate IP and technical capability to accelerate Genesis Systems' Water-as-a-Service offerings for defense, utilities and industrial end markets.

Enveric Biosciences Acquires MagicMed Industries

May 24, 2021

Biotechnology

Enveric Biosciences entered into a definitive all-stock agreement to acquire MagicMed Industries, a Calgary-based biotechnology company focused on psychedelic-derived drug discovery, in an amalgamation that will make MagicMed an indirect wholly owned subsidiary of Enveric. The deal expands Enveric’s pipeline beyond cannabinoids into psychedelic-derived molecules (psilocybin, DMT derivatives, etc.), includes issuance of Enveric common stock and equity awards to MagicMed shareholders, and contemplates leadership changes with Dr. Joseph Tucker named CEO upon closing.